Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Goodwill (2023 - 2025)

Inventiva (IVA) posted quarterly Goodwill of $43069.6 for Q4 2025, up 8.93% year-over-year from $39538.0 in Q4 2024, and up 2.83% quarter-over-quarter from $41882.5 in Q2 2025.

Analysis

Inventiva (IVA) Goodwill (2023 - 2025) Analysis & Trends

Inventiva's Goodwill history runs 3 years deep, the most recent figure standing at $43069.6 for Q4 2025.

  • In Q4 2025, Goodwill rose 8.93% year-over-year to $43069.6; the TTM figure through Dec 2025 stood at $43069.6 (up 8.93% YoY), while the FY2025 annual figure was $43069.6, up 8.93% from the prior year.
  • Goodwill for Q4 2025 stood at $43069.6, up from $41882.5 in the prior quarter.
  • The five-year high for Goodwill was $43069.6 in Q4 2025, with the low at $39538.0 in Q4 2024.
  • The 3-year median for Goodwill is $40885.7 (2023), against an average of $41044.1.
  • The sharpest annual moves came in 2024 and 2025: Goodwill retreated 3.3% in 2024, then gained 8.93% in 2025.
  • Inventiva's Goodwill stood at $40885.7 in 2023, then decreased by 3.3% to $39538.0 in 2024, then increased by 8.93% to $43069.6 in 2025.
  • Business Quant data shows IVA's Goodwill at $43069.6 in Q4 2025, $41882.5 in Q2 2025, and $39538.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Inventiva 893.85 Mn 893.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 43,069.61
Jun 30, 2025 41,882.51
Dec 31, 2024 39,538.03
Jun 30, 2024 39,844.84
Dec 31, 2023 41,961.66